• Explore /
  • Poster
  • / EORTC-1203: Integration of trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy (CT) of HER-2 positive stomach cancer—INNOVATION trial.

EORTC-1203: Integration of trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy (CT) of HER-2 positive stomach cancer—INNOVATION trial.

Abstract Poster

Authors

null

Anna Dorothea Wagner

Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland

Anna Dorothea Wagner , Yoon-Koo Kang , Jolanda van Dieren , Murielle E. Mauer , Heike I Grabsch , Michela Lia , Ajlan Atasoy , Jae Yong Cho , Markus H. Moehler , Arnaud Roth , Manuel Salto-Tellez , Christoph Schumacher , Nicole C.T. van Grieken , Johanna W. van Sandick , Florian Lordick

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT02205047

Citation

J Clin Oncol 34, 2016 (suppl; abstr TPS4133)

DOI

10.1200/JCO.2016.34.15_suppl.TPS4133

Abstract #

TPS4133

Poster Bd #

124a

Abstract Disclosures

Similar Posters

First Author: Anna Dorothea Wagner

First Author: Seyoung Seo

First Author: Yelena Y. Janjigian

First Author: Yelena Y. Janjigian